This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Université Libre De Bruxelles, Vrije Universiteit Brussel. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 99 
1 out of 192 
Years Active: 2022
Title: Innovations in Targeting Pancreatic Beta Cells: The Work of Sam Marc Kris Aimé Massa
Introduction
Sam Marc Kris Aimé Massa is an innovative inventor based in Hoeilaart, Belgium. He has made significant contributions to the field of medical science, particularly in the study of pancreatic beta cells. With one patent to his name, his work focuses on identifying a biomarker that plays a crucial role in understanding various health conditions related to these vital cells.
Latest Patents
Massa's notable invention is titled "Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells." This patent is directed towards the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. This unique candidate is significant for developing imaging and targeting strategies to study the pancreatic beta cell mass in both health and various diseases including Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), pancreatic cancers, obesity, islet transplantation, and beta cell regeneration.
Career Highlights
Throughout his career, Massa has collaborated with eminent research institutions and universities, notably the Université Libre De Bruxelles and Vrije Universiteit Brussel. His work has contributed greatly to advancements in biomedical sciences, particularly in relation to diabetes and pancreatic health.
Collaborations
Massa has had the opportunity to work alongside esteemed colleagues in the field, such as Eizirik Decio Laks and Alexander Balhuizen. These collaborations have intensified research efforts and enhanced the understanding of pancreatic beta cells and their implications in various diseases.
Conclusion
Sam Marc Kris Aimé Massa exemplifies a dedicated inventor whose research advances the field of medical science. Through his innovative patent on pancreatic beta cell biomarkers, he opens new avenues for studying critical health issues. His journey is a testament to the impactful role of inventors in improving our understanding of complex biological systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile